144 related articles for article (PubMed ID: 25222735)
1. A phase IIA dose-finding study of PVP-hypericin fluorescence cystoscopy for detection of nonmuscle-invasive bladder cancer.
Straub M; Russ D; Horn T; Gschwend JE; Abrahamsberg C
J Endourol; 2015 Feb; 29(2):216-22. PubMed ID: 25222735
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence diagnosis of bladder cancer with new water soluble hypericin bound to polyvinylpyrrolidone: PVP-hypericin.
Kubin A; Meissner P; Wierrani F; Burner U; Bodenteich A; Pytel A; Schmeller N
Photochem Photobiol; 2008; 84(6):1560-3. PubMed ID: 18627521
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution of PVP-hypericin and hexaminolevulinate-induced PpIX in normal and orthotopic tumor-bearing rat urinary bladder.
Vandepitte J; Van Cleynenbreugel B; Hettinger K; Van Poppel H; de Witte PA
Cancer Chemother Pharmacol; 2011 Apr; 67(4):775-81. PubMed ID: 20532886
[TBL] [Abstract][Full Text] [Related]
4. Is photodynamic diagnosis using hypericin better than white-light cystoscopy for detecting superficial bladder carcinoma?
Sim HG; Lau WK; Olivo M; Tan PH; Cheng CW
BJU Int; 2005 Jun; 95(9):1215-8. PubMed ID: 15892804
[TBL] [Abstract][Full Text] [Related]
5. Improved detection of nonmuscle invasive urothelial carcinoma of the bladder using pirarubicin endoscopy: a prospective, single-center preliminary study.
Han J; Lin T; Xu K; Jiang C; Huang H; Yin X; Xie W; Yao Y; Zhang C; Huang J
J Endourol; 2010 Nov; 24(11):1801-6. PubMed ID: 20932082
[TBL] [Abstract][Full Text] [Related]
6. Hypericin-based fluorescence diagnosis of bladder carcinoma.
D'Hallewin MA; Kamuhabwa AR; Roskams T; De Witte PA; Baert L
BJU Int; 2002 May; 89(7):760-3. PubMed ID: 11966641
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin.
D'Hallewin MA; De Witte PA; Waelkens E; Merlevede W; Baert L
J Urol; 2000 Aug; 164(2):349-51. PubMed ID: 10893582
[TBL] [Abstract][Full Text] [Related]
8. Spectroscopic and photostability study of water-soluble hypericin encapsulated with polyvinylpyrrolidone.
Abdelhamid S; Sharaf A; Youssef T; Kassab K; Salaheldin TA; Zedan AF
Biophys Chem; 2020 Nov; 266():106454. PubMed ID: 32795732
[TBL] [Abstract][Full Text] [Related]
9. Improved detection and treatment of bladder cancer using hexaminolevulinate imaging: a prospective, phase III multicenter study.
Jocham D; Witjes F; Wagner S; Zeylemaker B; van Moorselaar J; Grimm MO; Muschter R; Popken G; König F; Knüchel R; Kurth KH
J Urol; 2005 Sep; 174(3):862-6; discussion 866. PubMed ID: 16093971
[TBL] [Abstract][Full Text] [Related]
10. [Clinical experience with intravesical instillations of 5-aminolevulinic acid (5-ALA) for the photodynamic diagnosis using fluorescence cystoscopy for bladder cancer].
Inoue K; Karashima T; Kamada M; Kurabayashi A; Ohtsuki Y; Shuin T
Nihon Hinyokika Gakkai Zasshi; 2006 Jul; 97(5):719-29. PubMed ID: 16898595
[TBL] [Abstract][Full Text] [Related]
11. Macro-microscopic fluorescence of human bladder cancer using hypericin fluorescence cystoscopy and laser confocal microscopy.
Olivo M; Lau W; Manivasager V; Tan PH; Soo KC; Cheng C
Int J Oncol; 2003 Oct; 23(4):983-90. PubMed ID: 12963977
[TBL] [Abstract][Full Text] [Related]
12. A phase III, multicenter comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of superficial papillary lesions in patients with bladder cancer.
Grossman HB; Gomella L; Fradet Y; Morales A; Presti J; Ritenour C; Nseyo U; Droller MJ;
J Urol; 2007 Jul; 178(1):62-7. PubMed ID: 17499283
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence detection of bladder cancer: a review.
D'Hallewin MA; Bezdetnaya L; Guillemin F
Eur Urol; 2002 Nov; 42(5):417-25. PubMed ID: 12429148
[TBL] [Abstract][Full Text] [Related]
14. How to make hypericin water-soluble.
Kubin A; Loew HG; Burner U; Jessner G; Kolbabek H; Wierrani F
Pharmazie; 2008 Apr; 63(4):263-9. PubMed ID: 18468384
[TBL] [Abstract][Full Text] [Related]
15. The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA).
Inoue K; Matsuyama H; Fujimoto K; Hirao Y; Watanabe H; Ozono S; Oyama M; Ueno M; Sugimura Y; Shiina H; Mimata H; Azuma H; Nagase Y; Matsubara A; Ito YM; Shuin T
Photodiagnosis Photodyn Ther; 2016 Mar; 13():91-96. PubMed ID: 26751700
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5-aminolaevulinic acid.
Koenig F; McGovern FJ; Larne R; Enquist H; Schomacker KT; Deutsch TF
BJU Int; 1999 Jan; 83(1):129-35. PubMed ID: 10233465
[TBL] [Abstract][Full Text] [Related]
17. A comparison of hexaminolevulinate fluorescence cystoscopy and white light cystoscopy for the detection of carcinoma in situ in patients with bladder cancer: a phase III, multicenter study.
Fradet Y; Grossman HB; Gomella L; Lerner S; Cookson M; Albala D; Droller MJ;
J Urol; 2007 Jul; 178(1):68-73; discussion 73. PubMed ID: 17499291
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence cystoscopy: is it ready for use in routine clinical practice?
Spiess PE; Grossman HB
Curr Opin Urol; 2006 Sep; 16(5):372-6. PubMed ID: 16905985
[TBL] [Abstract][Full Text] [Related]
19. Optimizing the antitumor selectivity of PVP-Hypericin re A549 cancer cells and HLF normal cells through pulsed blue light.
Penjweini R; Loew HG; Breit P; Kratky KW
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):591-9. PubMed ID: 24284116
[TBL] [Abstract][Full Text] [Related]
20. Blue light cystoscopy for the diagnosis of bladder cancer: Results from the US prospective multicenter registry.
Daneshmand S; Bazargani ST; Bivalacqua TJ; Holzbeierlein JM; Willard B; Taylor JM; Liao JC; Pohar K; Tierney J; Konety B;
Urol Oncol; 2018 Aug; 36(8):361.e1-361.e6. PubMed ID: 29859728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
